Target intelligence / Profile preview

RNA, U4 small nuclear 62, pseudogene (RNU4-62P)

Target
RNU4-62P
Molecular classification
Non-coding RNA, Pseudogene, Small nuclear RNA (snRNA, pseudogene)
01

Overview

RNU4-62P (RNA, U4 small nuclear 62, pseudogene) is annotated as a pseudogene corresponding to the U4 small nuclear RNA, a component found within the spliceosome complex in eukaryotic cells[1]. Unlike its functional counterparts (such as RNU4-2), RNU4-62P is not protein-coding and is generally believed to lack biological function; there are no reported associations with diseases or therapeutic targeting for this pseudogene, nor any drug interactions or biomarker utility. RNU4-62P should not be confused with the active RNU4-2 gene, which encodes a snRNA essential for pre-mRNA splicing and is implicated in neurodevelopmental disorders. As a pseudogene, RNU4-62P is not considered a functional molecular target[1]. Note: - There is confusion risk: RNU4-2 (not RNU4-62P) is the gene implicated in spliceosome biology and neurodevelopmental disorders[2][3][5]. - RNU4-62P is most likely not a true target; all therapeutic, pathological, and mechanistic findings in current research relate to RNU4-2, not the pseudogene[1][3][5]. - If the query intended to reference the functional U4 snRNA or RNU4-2, supplementary clarification would be needed.

Other names
RNU4-62P
02

Biological functions

Other (pseudogene, likely non-functional)
03

Disease associations

Other (no known disease association for RNU4-62P pseudogene specifically)

Beyond the preview

Go deeper on RNA, U4 small nuclear 62, pseudogene (RNU4-62P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U4 small nuclear 62, pseudogene (RNU4-62P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call